Sedation and Analgesia for Reduction of Pediatric Ileocolic Intussusception

Naveen Poonai1, Daniel M Cohen2, Doug MacDowell2

  • 1Departments of Pediatrics, Internal Medicine, Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

JAMA Network Open
|June 7, 2023
PubMed

Insights

Most children with ileocolic intussusception reduction did not receive analgesia or sedation. These interventions were not linked to perforation or failed reduction, questioning current practices.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Clinical Outcomes

Background:

  • Ileocolic intussusception is a common cause of intestinal obstruction in children.
  • Reduction via air or fluid enema is standard but often performed without pain management.
  • Practice variation exists regarding sedation and analgesia during this procedure.

Purpose of the Study:

  • To determine the prevalence of opioid analgesia and sedation during ileocolic intussusception reduction.
  • To assess the association between analgesia/sedation and intestinal perforation.
  • To evaluate the relationship between analgesia/sedation and reduction success.

Main Methods:

  • Cross-sectional study of medical records from 86 institutions across 14 countries.
  • Included 3203 children aged 4-48 months undergoing ileocolic intussusception reduction.
  • Analyzed data on opioid use, sedation, perforation, and reduction success.

Main Results:

  • Over two-thirds of patients received no analgesia or sedation.
  • Opioid use was 12.6%, sedation 10.6%, and both 5.7%.
  • Neither analgesia nor sedation was significantly associated with intestinal perforation or failed reduction in adjusted analyses.

Conclusions:

  • The study challenges the routine withholding of analgesia and sedation for pediatric intussusception reduction.
  • Findings suggest current practices may not be supported by evidence regarding safety and efficacy.
  • Further research may inform updated guidelines on pain management during this procedure.
Abstract

Related Concept Videos

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
128
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
174
Endoscopic Procedures II: Colonoscopy01:25

Endoscopic Procedures II: Colonoscopy

The colon, or large intestine, is the final segment of the digestive system. Its primary functions include absorbing water and vitamins produced by gut bacteria and transforming waste from liquid to solid to form stool. In adults, the large intestine is approximately 5 feet long and consists of four main sections:
142
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
236
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
219
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
163